{
    "nctId": "NCT01312012",
    "officialTitle": "The Effectiveness and Feasibility of Using Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test and Follow-up Study",
    "inclusionCriteria": "- pregnant women in 30 to 32 weeks of gestation, with positive HBsAg and HBeAg,serum viral load above 8log10 copies per mL\n* Must be FEMALE\n* Must have minimum age of 20 Years\n* Must have maximum age of 40 Years",
    "exclusionCriteria": "* major systemic disease\n* Pregnant woman with infection of human immunodeficiency virus or hepatitis C virus\n* Pregnant woman is receiving any drug with antiviral activity or any form of drug therapy for hepatitis B virus\n* Pregnant woman whose ultrasonographic examination reveals congenital anomaly of the fetus\n* Pregnant woman whose amniocentesis reveals any genetic abnormality"
}